ISRCTN12210850
已完成
未知
Assessment of the predictive value of cardiac MRI in anthracycline-induced cardiomyopathy in sarcoma patients
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Anthracycline-induced cardiomyopathy in patients with sarcoma
- 发起方
- Charité University Medicine Berlin
- 入组人数
- 60
- 状态
- 已完成
- 最后更新
- 6年前
概览
简要总结
- 2018 results in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073029 (added 03/07/2019) 2. 2020 results in https://www.ncbi.nlm.nih.gov/pubmed/30786898 (added 29/01/2020)
研究者
入排标准
入选标准
- •1\. Histologically confirmed sarcoma diagnosis
- •2\. Planned chemotherapy with anthracyclines (cumulative dose \>300 mg/m2 doxorubicin\-equivalent)
- •3\. Age at least 18 years (no upper limit)
排除标准
- •1\. Any contraindication for contrast\-based MRI
- •2\. Chronic renal failure (glomerular filtration rate \<30ml/min)
- •3\. Previous participation in this study
结局指标
主要结局
未指定
相似试验
招募中
不适用
Cardiac MRI in the prediction of outcomes in advanced cardiomyopathyACTRN12616000727448Baker IDI Heart and Diabetes Institute240
已完成
不适用
Potential Ability of Cardiac MRI to Predict Efficacy after Cardiac Resynchronization TherapyHeart failureJPRN-UMIN000036415Tokai University Hospital130
进行中（未招募）
不适用
Magnetic resonance imaging in patients with chronic total occlusions of the coronary arteriesChronic total coronary occlusion (CTO)Circulatory SystemISRCTN33203221Heart Clinic Ulm100
进行中（未招募）
不适用
fMRI in CardiaC arrEst With Uncertain PrognosisCardiac ArrestNCT06423768Brigham and Women's Hospital50
已完成
不适用
Comprehensive risk assessment by cardiac MRI and PET in patients with diastolic heart failureChronic heart failure with LVEF more than and equal 40%JPRN-UMIN000009386Hokkaido University Guraduate School of Medicine53